Novartis ( NYSE: NVS) said on Thursday that it received US FDA's accelerated approval for Vanrafia as a treatment for adults ...

A rare syndrome linked to purple urine reveals surprising insights into bacterial colonisation, metabolism, and risks for ...

The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary ...

When Novartis bought kidney disease biotech Chinook Therapeutics in 2023 for $3.2 billion upfront, the deal included a ...

The FDA has granted accelerated approval to Vanrafia to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.

In an interview with HT Lifestyle, Dr Abhishek Agrawal, Consultant urologist, Jupiter Hospital Thane explained why t turns ...

While there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and the best treatment outcomes. Pain resulting from bone lo ...

Methods We have created a urine proteomic assay containing a panel of biomarkers designed to measure disease-related pathology which include the inflammatory system, lysosome, heart, kidney, ...

There is growing concern that plastics may also be responsible for significant harm to the earth’s environment and human ...

For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments. More than 12.